Trader make big bet on Eli Lilly
A trader took a big position in Eli Lilly and Co. (LLY) Tuesday morning. So far, 10,144 contracts of the Oct 110 call have changed hands, against open interest of 177 contracts. The bulk of today’s volume, 9,875 contracts, came in a single trade at 11:13 this morning. That trade, and most of today’s other trades were made in the high half of the bid-ask spread, indicating these new contracts were initiated from the buy side.
Already a member?
Login to see your Unusual Options Activity Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Eli Lilly and Company
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.